Condition: Arthritis, Rheumatoid · Sponsor: The Bionics Institute of Australia
This open label clinical trial aims to assess the safety of abdominal vagus nerve stimulation (aVNS) for moderate to severe, adult-onset rheumatoid arthritis (RA) that has not responded to medication. The aVNS is an active medical device placed into the body to allow electrical stimulation of the abdominal vagus nerve. Participants will undergo stimulation treatment with the aVNS device from two to 24 weeks after the device is implanted by keyhole surgery. Safety, device performance and potential benefits will be assessed. Participants will be monitored for specific events for 5 years post surgery.
This description comes directly from the study's public registry record.
A/Prof Shereen Oon, MBBS, PhD · +61392311203 · rheumclintrials@svha.org.au
Angela Chia, RN · +61392311203 · rheumclintrials@svha.org.au
Always discuss trial participation with your own doctor first.
| Bionics Institute | Fitzroy, Victoria, Australia | Recruiting |
| St Vincent's Hospital, Department of Rheumatology | Fitzroy, Victoria, Australia | Recruiting |
| Austin Health, Heidelberg Repatriation Hospital | Ivanhoe, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07017686